Visuel - Landing page

 Our latest publications released

🔎 Using primary care data to assess comparative effectiveness and safety of apixaban and rivaroxaban in patients with nonvalvular atrial fibrillation in the UK: an observational cohort study (BMJ Journal, 2022)

🔎 Association of adherence to endocrine therapy among patients with breast cancer an potential drug-drug interactions (JAMA network, 2022)

🔎 Psoriasis and alterations in quality of life at work: a study with data from the THIN® database France cross-referenced with social network content analyzed by the Detec't® tool (Journal of Epidemiology & Public Health, 2022)

🔎 Identification of the type of diabetes by modeling through the consumption of care and the characteristics of patients in pharmacies (Journal of Epidemiology & Public Health, 2022)

🔎 And many more...

About THIN®️

THIN®️ (The Health Improvement Network) is a large European database of anonymized Electronic Health Records collected at the physicians’ level, owned by the Cegedim group.

THIN®️ anonymized longitudinal patient data currently covers large populations of over 69 million patients across several European countries (France, the UK, Spain, Italy, Belgium and Romania). 

The THIN®️ database is referenced by leading healthcare authorities in France, in the UK and at European level. It also assists academics and research centers with healthcare research and analysis, and more than 1800 scientific papers have been published worldwide. 

Cegedim Health Data provides anonymized Real-World Data and Evidence (RWD-E) platforms and advanced studies to drive cutting-edge improvements in patient outcomes in the interests of public health.

Ask for RWD expertise or datasets